EVIDENS
Live / Applied — First extension granted (statement of use) (as of 23 Feb 2026)
What this means for you
Not registered yet, but its 20 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98761419
- Mark type
- Stylized text
- Filed
- 20 Sept 2024
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Jelena Libby
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable and recorded computer software for collecting and retaining patient data relating to diseases and for creating a disease registry; downloadable mobile application for collecting and retaining patient data relating to diseases and for creating a disease registry; downloadable and recorded computer software applications and platforms, for collecting and analyzing patient data in the medical field
- Class 035 — Advertising and business services: Electronic data collection for business purposes in the medical field
- Class 042 — Scientific and technological services: Platform as a service (PAAS) services featuring computer software platforms for collecting and retaining patient data relating to the medical field
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 24 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Feb 2026 — SOU EXTENSION 1 GRANTED
- 23 Feb 2026 — SOU EXTENSION 1 FILED
- 23 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION WRITTEN